Triosephosphate isomerase deficiency: Historical perspectives and molecular aspects

Best Practice and Research: Clinical Haematology

Volumn 13, Issue 1, 2000, Pages 119-140

  Schneider, Arthur S ^a,b  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Enzyme replacement; Haplotypes; Hereditary haemolytic anaemia; Membrane lipids; Mutations; Neuromuscular degeneration; Structure function; Triosephosphate isomerase

Indexed keywords

ASPARTIC ACID; GLUTAMIC ACID; GLUTATHIONE; TRIOSEPHOSPHATE ISOMERASE;

AFRICA; ASIAN; CATALYSIS; CELL CULTURE; CELL TRANSFER; ENZYME DEFICIENCY; ENZYME REPLACEMENT; FEMALE; GENE MUTATION; GENE THERAPY; HAPLOTYPE; HISTORY; HUMAN; LIPID METABOLISM; MOLECULAR BIOLOGY; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; STRUCTURE ACTIVITY RELATION;

EID: 0034431493     PISSN: 15216926     EISSN: None     Source Type: Journal    
DOI: 10.1053/beha.2000.0061     Document Type: Article

References (106)

1. A new erythrocyte enzyme defect with hemolytic anemia-triosephosphate isomerase (TPI) disease
2. Hereditary hemolytic anemia with triosephosphate isomerase deficiency
3. Autohemolysis and other changes resulting from incubation in vitro of red cells from patients with congenital hemolytic anemia
4. Erythrocyte triosephosphate isomerase deficiency
5. Hereditary hemolytic anemia with triosephosphate isomerase deficiency: Studies in kindreds with coexistent sickle cell trait and erythrocyte glucose-6-phosphate dehydrogenase deficiency
6. Triosephosphate isomerase deficiency: Repetitive occurrence of point mutation in amino acid 104 in multiple apparently unrelated families
7. Triosephosphate isomerase deficiency in a child with congenital hemolytic anemia and severe hypotonia
8. The pattern of glycolysis in erythrocyte triosephosphate isomerase deficiency
9. Triosephosphate isomerase deficiency. B. Inherited triosephosphate isomerase deficiency. Erythrocyte carbohydrate metabolism and preliminary studies of the erythrocyte enzyme
10. Isoenzymes of triosephosphate isomerase in human erythrocytes
11. Electrophoretic abnormality in triosephosphate isomerase deficiency
12. Triosephosphate isomerase deficiency
13. Triosephosphate isomerase deficiency. A. A multisystem inherited enzyme disorder. Clinical and genetic aspects
14. Triosephosphate isomerase deficiency in an adult
15. A case of triosephosphate isomerase deficiency with sudden death
16. Evidence for synteny between the human loci for triose phosphate isomerase, lactate dehydrogenase-B, and peptidase-B and the regional mapping of these loci on chromosome 12
17. Regional mapping of TPI, LDH-B, and Pep-B on chromosome 12 of man
18. Anémie hémolytique congénitale par déficit en triosephosphate-isomérase
19. 12p ter → 12p 12.2: Possible assignment of human triose phosphate isomerase
20. Triose phosphate isomerase deficiency
21. Triosephosphate isomerase deficiency with hemolytic anemia and severe neuromuscular disease. Familial and biochemical studies of a case found in Spain
22. Hereditary deficiency of triosephosphate isomerase in four unrelated families
23. Frequency of enzyme deficiency variants in erythrocytes of newborn infants
24. Characterization of two new electrophoretic variants of human triosephosphate isomerase: Stability, kinetic, and immunological properties
25. Triosephosphate isomerase deficiency: A case report with neuropathological findings
26. Elevated frequency of carriers for triosephosphate isomerase deficiency in newborn infants
27. Déficit de triosa fosfato isomerasa: A propósito de dos nuevas observaciones
28. The frequency among Japanese of heterozygotes for deficiency variants of II enzymes
29. Prevalence of partial deficiency of red cell triosephosphate isomerase in Germany - A study of 3000 people
30. Triosephosphate isomerase deficiency: 2 cases
31. Hereditary triosephosphate isomerase deficiency: Seven new homozygous cases
32. Neurological findings in triosephosphate isomerase deficiency
33. Triose phosphate isomerase deficiency: Prenatal diagnosis
34. Triose phosphate isomerase deficiency: Report of a family
35. Platelet function defect in triosephosphate isomerase deficiency
36. Possibility of prenatal diagnosis of hereditary triose phosphate isomerase deficiency
37. Un cas d'anémie hémolytique congénitale non sphérocytaire, par déficit en triose phosphate isomérase. Diagnostic prénatal
38. Le déficit en triose phosphate isomérase. Enquete familiale et dépistage antenatal
39. First trimester studies of a fetus at risk for triose phosphate isomerase deficiency
40. Stable clinical course in a child with severe triose phosphate isomerase (TPI) deficiency managed with supportive care
41. Déficit de triosafosfato isomerasa. A propósito de una nueva observación
42. Prenatal diagnosis of a red-cell enzymopathy: Triose phosphate isomerase deficiency
43. Prenatal diagnosis of triose phosphate isomerase deficiency
44. A unique experiment of nature (a 21 yr old symptom free homozygote for triose phosphate isomerase [TPI] deficiency)
45. Hereditary triosephosphate isomerase (TPI) deficiency: Two severely affected brothers, one with and one without neurological symptoms
46. Myopathy with altered mitochondria due to a triosephosphate isomerase (TPI) deficiency
47. Triosephosphate isomerase deficiency: Haemolytic anaemia, myopathy with altered mitochondria and mental retardation due to a new variant with accelerated enzyme catabolism and diminished specific activity
48. Origin of the triosephosphate isomerase isozymes in humans: Genetic evidence for the expression of a single structural locus
49. Characterization of the functional gene and several processed pseudogenes in the human triosephosphate isomerase gene family
50. Characteristics of enzymes of erythrocytes from newborn infants and adults: Activity, thermostability, and electrophoretic profile as a function of cell age
51. Prenatal diagnosis of triose phosphate isomerase deficiency
52. Evidence for founder effect of the Glu104Asp substitution and identification of new mutations in triosephosphate isomerase deficiency
53. The amino acid sequence of rabbit muscle triose phosphate isomerase
54. Triose phosphate isomerase from the coelacanth
55. Studies on the subunit structure and amino acid sequence of triose phosphate isomerase from chicken breast muscle
56. A new troponin T and cDNA clones for 13 different muscle proteins, found by shotgun sequencing
57. Human triosephosphate isomerase cDNA and protein structure: Studies of triosephosphate isomerase deficiency in man
58. Minimal sequence and factor requirements for the initiation of transcription from an atypical, TATATAA box-containing housekeeping promoter
59. Human triose-phosphate isomerase deficiency: A single amino acid substitution results in a thermolabile enzyme
60. Premature translation termination mediates triosephosphate isomerase mRNA degradation
61. Human triosephosphate isomerase deficiency resulting from mutation of Phe-240
62. Primary structure of human triosephosphate isomerase
63. mRNA-deficient beta o-thalassemia results from a single nucleotide deletion
64. Unstable beta-globin mRNA in mRNA-deficient beta o thalassemia
65. When cells stop making sense: Effects of nonsense codons on RNA metabolism in vertebrate cells
66. New case of codon 104 (Glu → Asp) mutation in homozygous triose phosphate isomerase deficiency and possible prenatal diagnosis of this disease
67. Relation between genetic defect, altered protein structure, and enzyme function in triose-phosphate isomerase (TPI) deficiency
68. Triosephosphate isomerase deficiency: Biochemical and molecular genetic analysis for prenatal diagnosis
69. Triosephosphate isomerase deficiency: Two Italian cases associated to mutation 104 (315G → C, 105 Glu → Asp)
70. Human triosephosphate isomerase: Substitution of Arg for Gly at position 122 in a thermolabile electromorph variant, TPI-Manchester
71. Red cell membrane alterations in triosephosphate isomerase (TPI) deficiency
72. Erythrocyte lipids in triose-phosphate isomerase deficiency
73. Membrane fluidity, active calcium transport and acetylcholinesterase activity of red cells in triosephosphate isomerase (TPI) deficiency
74. Triosephosphate isomerase deficiency: Predictions and facts
75. Decrease in non-bilayer forming lipid composition of lymphocytes in triosephosphate isomerase (TPI) deficiency
76. Search for the pathogenesis of the differing phenotype in two compound heterozygote Hungarian brothers with the same genotypic triosephosphate isomerase deficiency
77. Déficiences en enzymes glycolitiques et neurodégénérescence
78. Chronic oxydative stress in triosephosphate isomerase deficiency and its role in the neurodegenerative process
79. Decrease in plasmalogen content in triosephosphate isomerase (TPI) deficiency
80. Hematologically important mutations: Triosephosphate isomerase
81. Identical germ-line mutations in the triosephosphate isomerase alleles of two brothers are associated with distinct clinical phenotypes
82. Glycerolipid biosynthesis in peroxisomes via the acyl dihydroxyacetone phosphate pathway
83. Enhanced association of mutant triosephosphate isomerase to red cell membranes and to brain microtubules
84. Molecular pathology of human triosephosphate isomerase
85. Molecular basis of triosephosphate isomerase deficiency
86. Decrease and structural modifications of phosphatidylethanolamine plasmalogen in the brain with Alzheimer disease
87. Triose phosphate isomerase (TPI) deficiency due to point mutation in amino acid 104: Two previously undescribed families
88. Molecular diagnosis of the amino acid 104 mutation in triosephosphate isomerase (TPI) deficiency by Ddel restriction digest of PCR-amplified genomic DNA
89. The amino acid 104 mutation in triosephosphate isomerase (TPI) deficiency: Evidence for a single mutation in a common ancestor of seemingly unrelated families
90. Molecular pathology of human triosephosphate isomerase
91. All known cases of the triosephosphate isomerase (TPI) deficiency amino acid 104 mutation result from a single mutation in a common ancestor
92. The 1591C mutation in triosephosphate isomerase (TPI) deficiency. Tightly linked polymorphisms and a common haplotype in all known families
93. Molecular analysis of a series of alleles in humans with reduced activity at the triosephosphate isomerase locus
94. Transcriptional regulatory sequences of the housekeeping gene for human triosephosphate isomerase
95. Triosephosphate isomerase deficiency in three French families: Compound heterozygosity for the frameshift mutation (TPI Alfortville) with the frequent E105D mutation, an alteration in the initiation codon (TPI frequent promoter polymorphism, and homozygosity for the E105D mutation
96. Insights from molecular modeling into the mechanisms of impaired catalysis in triosephosphate isomerase (TPI) deficiency
97. Hereditary hemolytic anemia with triosephosphate isomerase (TPI) deficiency: Assignment of the known mutation sites to functional molecular domains of the enzyme protein
98. Structural analysis of human triosephosphate isomerase (TPI) mutants
99. New insights into the interrelationships of the -5, -8 and -24 mutations with triosephosphate isomerase (TPI) deficiency
100. The relationship of the -5, -8, and -24 variant alleles in African Americans to triosephosphate isomerase (TPI) enzyme activity and to TPI deficiency
101. The consequence of nucleotide substitutions in the triosephosphate isomerase (TPI) gene promoter
102. Metabolic correction of triose phosphate isomerase deficiency in vitro by complementation
103. The feasibility of replacement therapy for inherited disorder of glycolysis: Triosephosphate isomerase deficiency
104. Regulation of triosephosphate isomerase (TPI) gene expression in TPI deficient lymphoblastoid cells
105. Towards enzyme-replacement treatment in triosephosphate isomerase deficiency
106. Reversal of metabolic block in glycolysis by enzyme replacement in triosephosphate isomerase-deficient cells